Treatment schedule of patients treated according HOVON-44 protocol. Re-evaluation was performed after (R)-DHAP and (R)-VIM. In the case of partial or complete response, patients continued the treatment with (R)-DHAP. In a limited number of patients, nonresponse or toxicity was observed on (R)-DHAP. In this situation the third course consisted of (R)-VIM.